In-vitro contraction of the equine aortic valve.

This study researched the contraction of horse aortic valves in response to various agents, shedding light on potential mechanisms related to the functioning and disease conditions of similar valves in humans.

Research Objectives

The main aim of this research was to understand the contractile properties of the normal equine aortic valve. It is a part of the heart that is susceptible to non-inflammatory degenerative changes. This phenomenon, associated with aortic valvular regurgitation (AR) in horses, has characteristics similar to AR in humans. As such, furthering understanding in this area could potentially provide new insights into human biology and pathology.

Research Methodology

• The researchers conducted experiments on equine aortic valves in vitro (outside the organism) in organ baths. This was to isolate and closely observe the contractile behavior of the valves in response to various agents. These agents were angiotensin II, thromboxane-mimetic U44069, endothelin-1, 5-hydroxytryptamine, medetomidine, norepinephrine, and phenylephrine.
• Selective antagonists were also used. These are substances that bond with and deactivate specific receptors, confirming the involvement of these receptors in observing contractile responses.

Results and Findings

• Angiotensin II was found to be the most potent in causing valve contraction, followed by endothelin-1, U44069, medetomidine, norepinephrine, phenylephrine while 5-hydroxytryptamine did not cause contraction.
• The contractile response to angiotensin II was eliminated when the AT1 receptor antagonist Sar1-Ile8-Angiotensin II was introduced. The contraction due to U44069 was blocked by the thromboxane TXA2 receptor (TP) antagonist SQ29548.
• Endothelin-1’s contraction effect was stopped by the ET(A) receptor antagonist BQ123, but not by the ET(B) receptor antagonist BQ788.
• The contractile effects of phenylephrine were inhibited by Yohimbine, suggesting that an alpha-2 adrenoceptor-mediated response was involved.

Conclusions and Implication

The researchers found that equine aortic valves can contract in response to a range of physiologically significant endocrine, paracrine, and neuronal mediators. This suggested that valvular tone regulation could play an important role in the valve’s normal functioning. Therefore, a better understanding of these mechanisms might provide insights into the pathophysiology of naturally occurring equine aortic insufficiency. The horse can be considered as a useful model to study similar conditions in humans.